Antibióticos Naturais e Semissintéticos

<p>Applications Semi-synthetic cephalosporin antibiotic. Antibacterial.A representative lot contains some d5.<br>References Buck, R.E., et al.: Antimicrob. Agents Chemother., 11, 324 (1977),<br></p>

<p>Applications Labelled Ceftiofur (C244700). An antibacterial.<br>References Yancey, R.J., et al.: Am. J. Vet. Res., 48, 1050 (1987)<br></p>

<p>Applications 3-Chloro-D-alanine Methyl Ester Hydrochloride is an intermediate in the preparation of antibiotic D-Cycloserine (C988815) which inhibits cell wall biosynthesis in bacteria.<br>References Lamb., J.W., et al.: Anal. Profiles Drug Subs., 1, 53 (1972); Gentry-Weeks, C., et al.: J. Biol. Chem., 268, 7298 (1993); Alexander, F., et al.: Eur. J. Biochem., 219, 953 (1994); Auger, S., et al.: Biochimie, 87, 231 (2005); Chem and Eng. News p. 12, Dec. 7/14 (2015);<br></p>

<p>Impurity Amoxicillin EP Impurity L ; Amoxicillin USP Related Compound L<br>Stability Very Hygroscopic<br>Applications A derivative of Amoxicillin (A634235), a semi-synthetic antibiotic related to penicillin. Antibacterial.<br>References Brogden, R.N., et al.: Drugs, 18, 169 (1979), Bird, A.E., et al.: Anal. Profiles Drug Subs. Excip., 23, 1 (1994),<br></p>

<p>Stability Light Sensitive<br>Applications Desacetyl Rifaximin is an impurity of Rifaximin (R509500), a non-absorbable semisynthetic Rifamycin antibiotic.<br>References Brufani, M., et al.: J. Antibiot., 37, 1611 (1984); Gillis, J.C., et al.: Drugs, 49, 467 (1995); Huang, D.B., et al.: J. Infection, 50, 97 (2005)<br></p>

<p>Applications Semi-synthetic derivative of Abamectin; consists of a mixture of not less than 80% component B1a and not more than 20% component B1b. Anthelmintic (Onchocerca).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Chabala, J.C., et al.: J. Med. Chem., 23, 1134 (1980); Campbell, W.C., et al.: Science, 221, 823 (1983); Bennett, J.L., et al.: Parasitol. Today, 4, 226 (1988); Plaisier, A.P., et al.: J. Infect. Dis., 172, 204 (1995);<br></p>

<p>Stability Hygroscopic<br>Applications A labelled metabolite of Cefpodoxime Proxetil (C243860). An antibacterial.<br>References Fujimoto, K., et al.: J. Antibiot., 40, 370 (1987), Utsui, Y., et al.: Antimicrob. Agents Chemother., 31, 1085 (1987),<br></p>

<p>Impurity Ivermectin EP Impurity K<br>Applications 3,4-Dihydro Ivermectin is an impurity of Ivermectin (I940800), an antiparasitic drug that is active against a wide variety of nematode and arthropod parasites and is used to treat scabies and lice in humans. An invitro inhibitor of SARS-CoV-2/ Covid-19.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Campbell, W., et al.: Science, 221, 823 (1983); Glaziou, P., et al.: Trop. Med. Parasitol., 45, 253 (1994); Meinking, T., et al.: New Engl. J. Med., 333, 26 (1995); Caly, L., et al.: Antivir. Res., 178<br></p>

<p>Stability Light Sensitive<br>Applications A glycylcycline antibiotic, used to treat infection by drug resistant bacteria such as Staphylococcus aureus (Staph aureus) and Acinetobacter baumannii.<br>References Lim, T., et al.: J. Antibiotics, 62, 675 (2009), Presterl, E., et al.: Antimicrob. Agents Chemother., 53, 3205 (2009), Varma, M., et al.: J. Med. Chem., 52, 4844 (2009),<br></p>

<p>Applications Used as an antibacterial agent. LD50 &gt;5000 mg/kg for oral administration to rats.<br>References Goldenthal, E.I.: Toxicol. Appl. Pharmacol., 18, 185 (1971)<br></p>

<p>Applications Furaltadone is a metabolite of Nitrofuran in milk and an intermediate in the synthesis of AMOZ (A634600), a metabolite of Furaltadone Hydrochloride.<br>References Tribalat, L., et al.: Anal. Bioanal. Chem., 386, 2168 (2006); Chu, P., et al.: J. Agric. Food Chem., 55, 2129 (2007); Lim, A., et al.: J. Bacteriol., 181, 2252 (1999), Martin, A., et al.: J. Clin. Microbiol., 43, 1612 (2005), Chu, P., et al.: J. Agric. Food Chem., 55, 2129 (2007), McCracken, R., et al.: Food Addit. Contam., 24, 26 (2007),<br></p>

<p>Impurity Clavulanate Potassium EP Impurity A<br>Applications 2,5-Pyrazinediethanol (Clavulanate Potassium EP Impurity A) is an impurity of Clavulanic acid (C563750). High concentrations of Clavulanic acid but not of its degradation products decrease glycerol consumption and oxygen uptake rates in cultures of Streptomyces clavuligerus.<br>References Zupke, C., et al.: Biotechnol. Prog., 10, 489 (1994), Finlay, J., et al.: J .Antimicrob. Chemother., 52, 18 (2003), Alper, H., et al.: Science, 314, 1565 (2006), Brethauer, S., et al.: Biotechnol. Bioeng., 98, 356 (2007),<br></p>

<p>Stability Hygroscopic<br>Applications An intermediate in the preparation of labelled FK-506 (Tacrolimus)<br>References Rokaw, M.D., et al.: Am. J. Physiol., 271, C194 (1996), Knoll, G.A., et al.: Brit. Med. J., 318, 1104 (1999),<br></p>

<p>Impurity Moxifloaxacin EP Impurity D<br>Stability Hygroscopic<br>Applications 8-Fluoro-6-methoxy Moxifloxacin Dihydrochloride (Moxifloaxacin EP Impurity D) is an impurity of Moxifloxacin (M745000).<br>References Martel, A., et al.: Drugs Fut., 22, 109 (1997), Tobin, C., et al.: J. Antimicrob. Chemother., 42, 278 (1998),<br></p>

<p>Applications A metabolite of the fluorinated quinolone antibacterial Ciprofloxacin.<br>References Tiefenbacher, E., et al.: J. Pharm. Sci., 83, 463 (1994), Parshikov, I., et al.: App. Microbiol. Biotechnol., 56, 474 (2001),<br></p>

<p>Applications Anidulafungin, is a semisynthetic echinocandin that inhibits glucan synthase, an enzyme important in the formation of (1→3)-β-D-glucan, a major fungal cell wall component, and thus is used as antifungal drug.<br>References Denning, D. W., et al.: J. Antimicrob. Chemother, 40, 611 (1997); Vazquez, J. A., et al.: Clin. Ther., 27(6), 657 (2005);<br></p>

<p>Applications Desmycosin is a 16-membered macrolide antibiotic and a metabolite of Tylosin (T947650). Desmycosin is also a precursor to Tilmicosin (T440500).<br>References Wal, J.M. et al.: J. Antibiot., 26, 687 (1973); Hu, D. et al.: Environ. Toxicol. Chem., 26, 884 (2007); Min, Y. et al.: Proc. Biochem., 42, 729 (2007);<br></p>

<p>Impurity Ceftazidime EP Impurity A<br>Stability Hygroscopic, Light Sensitive<br>Applications ∆2-Ceftazidime, 90% (Ceftazidime EP Impurity A) is a Ceftazidime isomer, an impurity of Ceftazidime (C244100).<br>References Vilanova, B., et al.: Helv. Chim. Acta, 76, 2789 (1993), Zhou, M., et al.: J. Pharm. Sci., 84, 534 (1995), Baertschi, S., et al.: Chemother. 8, 353 (1997), Porra, R., et al.: J. Pharm. Biomed. Anal., 18, 241 (1998),<br></p>

<p>Impurity Amoxicillin EP Impurity G ; Amoxicillin USP Related Compound G<br>Applications p-Hydroxy-(D)-phenylglycyl Amoxicillin is a derivative of Amoxicillin (A634235) a semi-synthetic antibiotic related to Penicillin.<br>References Brogden, R.N., et al.: Drugs, 18, 169 (1979), Bird, A.E., et al.: Anal. Profiles Drug Subs. Excip., 23, 1 (1994),<br></p>

<p>Applications T 2588G Sodium Bisulfite is a more stable form of T 2588G (Cefepime EP Impurity C) (T003100) which is a metabolite of Cefditorin (ME1207) (C242700), a new oral cephem.<br>References Sugioka, T., et al.: Chem. Pharmaceut. Bull., 38, 1998 (1990)<br></p>

<p>Impurity Vancomycin Impurity<br>Applications An impurity in Vancomycin.A representative lot was 75% by HPLC with less than 0.1% vancomycin.<br>References Marshall, F.J., et al.: J. Med. Chem., 8, 18 (1965), Sheldrick, G.M., et al.: Nature, 271, 223 (1987), Dutca-Melan, S., et al.: J. Clin. Microbiol., 33, 24 (1995),<br></p>

<p>Impurity Cefaclor EP Impurity F/ Ampicillin EP Impurity H<br>Applications 2-Hydroxy-3-phenylpyrazine (Cefaclor EP Impurity F) is a degradation product of Cefaclor (C235250), a second-generation cephalosporin antibiotic.<br>References Baertschi, S.W., et al.: J. Pharma. Sci., 82, 622 (1993); Gray, B.M., et al.: Antimicrob. Agents Chemother., 13, 988 (1978), Lorenz, L.J., et al.: Anal. Profiles Drug Subs., 9, 107 (1980), Hori, R., et al.: J. Pharm. Pharmacol., 40, 646 (1988),<br></p>

<p>Impurity Amoxicillin EP Impurity C ; Amoxicillin USP Related Compound C<br>Applications Amoxicillin Diketopiperazine (Amoxicillin EP Impurity C) is a major metabolite of Amoxicillin (AMO)(A634235).<br>References Dewdney, J., et al.: Food Chem. Toxic, 29, 477 (1991), Connor, S., et al.: J. Pharm. Pharmacol., 46, 128 (1994), Hernandez, E., et al.: Vet. J., 170, 237 (2005),<br></p>

<p>Applications Linezolid is a prototype of the oxazolidinone antimicrobials; inhibits bacterial mRNA translation.<br>References Brickner, S.J., et al.: J. Med. Chem., 39, 673 (1996), Ford, C.W., et al.: Antimicrob. Agents Chemother., 40, 1508 (1996), Rybak, M.J., et al.: Pharmacotherapy, 18, 456 (1998), Stevens, D.L., et al.: Clin. Infect. Dis., 34, 1481 (2002),<br></p>

<p>Applications Moxifloxacin intermediate.<br></p>

<p>Applications Chloramphenicol-d5, is the labeled analogue of Chloramphenicol (C325030), which has a broad spectrum of activity against Gram-positive and gram-negative bacteria. It is also antibacterial, and antirickettsial.<br>References Bartz, et al.: J. Biol. Chem., et al.: 172, 445 (1948), Gottlieb, et al.: J. Bacteriol., 55, 409 (1948), Szulczewski, D., et al.: Anal. Profiles Drug Subs., 4, 47 (1975), Price, A., et al.: J. Antibiot., 43, 118 (1981), Shalit, I., et al.: Drugs, 28, 281 (1984),<br></p>

<p>Applications Tacrolimus Hydrate is a disease-modifying antirheumatic drugs (DMARDs)<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ogasawara, M., et al.: Mod. Rheumatol., 22, 831-836 (2012)<br></p>

<p>Impurity Azithromycin EP Impurity B<br>Applications Azithromycin B (Azithromycin EP Impurity B), is an impurity of Azithromycin (A927000), a semi-synthetic macrolide antibiotic, and related to Erythromycin A.<br>References Langtry, H.D., et al.: Drugs, 56, 273 (1998),<br></p>

<p>Applications N-Demethyl-N-(ethylsuccinyl) Erythromycin is an impurity of Erythromycin (E649950), an antibiotic that has a wider spectrum than penicillin (P223500).<br>References Koch, W.L., et al.: Anal. Profiles Drug Subs., 8, 157 (1979),<br></p>

<p>Applications Single factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. Antibacterial.<br>References Koch, K.F., et al.: Antimicrob. Agents Chemother., 309 (1970), Welles, J.S., et al.: Toxicol. Appl. Pharmacol., 22, 332 (1972), Dash, A.K., et al.: Anal. Profiles Drug Subs. Excip., 24, 579 (1996),<br></p>

<p>Applications A key intermediate in the manufacturing of Cephalosporin compounds.<br>References Choi, K., et al.: J. Antibio., 50, 279 (1997),<br></p>

<p>Applications Labelled Clarithromycin (C559750). Clarithromycin is a semi-synthetic macrolide antibiotic. Clarithromycin is a derivative of Erythromycin (E650000).<br>References Benson, C., et al.: Eur. J. Clin. Microbiol., 6, 173 (1987), Boyanova, L., et al.: J. Med. Microb., 61, 85 (2012), Lin, Z., et al.: Toxicol. Sci., 126, 114 (2012),<br></p>

<p>Applications Pseudomonic Acid C, is the analogue of Pseudomonic Acid D (P839520) which is an antibiotic isolated from Pseudomonas fluorescens.<br>References Banks, R.M., et al.: J. Antibiot., 41, 609 (1988);<br></p>

<p>Impurity Tacrolimus Related Compound A USP<br>Applications A potent immunosuppressive agent and could be used as a potential therapeutic agent for autoimmune diseases.<br>References Matuszewski, B., et al.: Anal. Chem., 75, 3019 (2003), Taylor, P., et al.: Clin. Chem., 51, 1890(2005);<br></p>

<p>Applications A key intermediate of cephem compounds.<br>References Chambers, H., et al.: Antimicrob. Agents Chemother., 39, 2620 (1995), Heinisch, L., et al.: J. Med. Chem., 45, 3032 (2002),<br></p>

<p>Stability Hygroscopic<br>Applications Amoxicillin dimer tri-Sodium Salt (penicilloic acid form) is an impurity of Amoxicillin (A634235), a β-lactam family antibiotic that is commonly used in conjunction with clavulanic acid (C56370) to the treat bacterial infections.<br>References Gurwith, M., et al.: Antimicrob. Agents Ch., 24, 716 (1983); Kumar, A., et al.: J. Mater. Chem., 20, 10152 (2010);<br></p>

<p>Aztreonam impurity D is a metabolite of aztreonam. Aztreonam impurity D is an impurity standard for the pharmacopoeia and API industry, as well as for drug development and research. It has been shown that this compound inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. Aztreonam impurity D also specifically binds to markers expressed at high levels in Mycobacterium tuberculosis strains (e.g., ESX-1 secretion system protein) and inhibits cell growth in culture.</p>

<p>Roxithromycin impurity K is a custom synthesis that is used as a research and development tool. It is not intended for use in drug products. Roxithromycin impurity K has been shown to have effects similar to those of roxithromycin, but with different metabolic pathways and properties. Roxithromycin impurity K has been shown to be metabolized through the cytochrome P450 system, which may result in the production of metabolites that are more potent than roxithromycin itself.</p>

<p>Caspofungin impurity C is a high-purity, chromatographically pure, caspofungin impurity. It was isolated by chromatography and was found to have a retention time of 12.5 minutes on the chromatogram. The impurity is thought to be an organic compound with a molecular weight of 437.2 and may be due to the presence of an acetyl group or hydroxyl group.</p>

<p>Erythromycin impurity N is a natural metabolite of erythromycin. It is a metabolite of erythromycin that has been identified in the metabolism studies of this drug product. Erythromycin impurity N is an analytical standard for use in pharmaceutical research and development, as well as in the pharmacopoeia. The CAS number for this compound is 527-56-8.</p>

<p>N-((-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl) acetamide is a custom synthesis, drug product, niche, Metabolite, Drug Development, CAS No. 224323-50-6. It is a natural compound and has pharmacopoeia and API impurity. It is an analytical standard for HPLC and research and development. It is a high purity synthetic with impurity standard.</p>

<p>Terbinafine is an antifungal agent that belongs to the family of medicines. It is used to treat fungal infections of the skin, nails and scalp. Terbinafine can also be used to treat other types of fungal infections, such as tinea corporis (ringworm), tinea cruris (jock itch), tinea pedis (athlete's foot) and tinea capitis (scalp ringworm). Terbinafine dimer impurity dihydrochloride is a by-product of terbinafine hydrochloride that has been shown to have industrial applications as a dispersant or lubricant in industries such as papermaking.</p>

<p>Desethylene ciprofloxacin hydrochloride is a metabolite of ciprofloxacin that is converted to the active form of the drug. Desethylene ciprofloxacin hydrochloride has a concentration-response relationship, which can be used for in vitro testing of pharmaceutical preparations. The chromatographic evaluation of this metabolite can be used to identify the presence of antibiotics in environmental samples. Desethylene ciprofloxacin hydrochloride is also a substrate for carbonyl reductase and piperazine, which are enzymes that produce an activated form of the metabolite.</p>

<p>CAS No. 37450-78-5, drug product, Custom synthesis, High purity, analytical, Metabolism studies, Natural, Drug development, pharmacopoeia, Metabolite, niche, Synthetic</p>

<p>Amikacin EP Impurity A is a metabolite of amikacin. It is a white crystalline substance with a molecular weight of 269.5. Amikacin EP Impurity A is found in the urine and bile of individuals who have been administered amikacin. It has been shown to be pharmacologically active, inhibiting bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication.</p>

<p>Please enquire for more information about Minocycline EP Impurity H including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Cefdinir impurity E is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development and analytical standard. CAS No. 946573-41-7 is the metabolite of cefdinir. It is used to study metabolism of cefdinir in vitro and in vivo. HPLC standards are available for this compound.</p>

<p>Tacrolimus is a macrolide antibiotic that binds to the calcineurin receptor and inhibits the production of cytokines. It is used to treat certain types of autoimmunity and hyperproliferation in patients with cancer, organ transplant recipients, and those who have undergone radiation therapy. The drug is available in two forms: tacrolimus (the natural form) and desmethyl tacrolimus (a metabolite). Desmethyl tacrolimus is produced by microbial transformation, which converts the natural form into a more water-soluble derivative. This conversion can be prevented by adding additives such as proton pump inhibitors or pde5 inhibitors. Symptoms of tacrolimus include hyperglycemia, hyperlipidemia, gastrointestinal disturbances, headache, fever, skin rash, diarrhea, and anemia. Tacrolimus has been shown to inhibit the activity of fk506-binding proteins in vitro and in vivo through competitive inhibition.</p>

<p>(S)-5-((tert-Butylamino)methyl)-3-(3-fluoro-(4-morpholinyl)phenyl)oxazolidin-2-one is a drug product with CAS No. 1215006-08-8, which is a metabolite of Fluoxetine. It is an impurity standard for Fluoxetine and has been used as a reference compound in metabolism studies. (S)-5-((tert-Butylamino)methyl)-3-(3-fluoro-(4-morpholinyl)phenyl)oxazolidin-2-one is also an analytical reagent that can be used to calibrate HPLC systems.</p>

<p>3-N-didesmethyl-3-N-tosyl azithromycin is an impurity of azithromycin. It is a white crystalline solid that is soluble in methanol and acetone, but insoluble in water. 3-N-didesmethylazithromycin has been shown to be a metabolite of azithromycin, which can be found as an impurity in the drug product.</p>

<p>(R)-3-(3-Fluoro-4-morpholin-4-ylphenyl)-2-oxo-5-oxazolidinyl)methyl methansulfonate is a Custom synthesis, drug product, Metabolite, Synthetic, Drug development, Impurity standard, Metabolism studies, API impurity, Natural, pharmacopoeia, analytical and HPLC standard. It is CAS No. 174649-09-3.</p>

<p>N-tert-butyl-N-(((S)-3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide (CAS 1215006-11, API impurity) is a synthetic compound from the drug development process. This impurity has been identified in the natural product and is not an active ingredient. It is found as a Metabolite in the pharmacopoeia and analytical methods. This substance is used for research and development of drugs, such as for standardizing HPLC.</p>

<p>5-((tert-Butylamino)methyl)-3-(3-fluoro-(2-morpholinyl)phenyl)oxazolidin-2-one (5FAMPO) is a metabolite of the drug product, CAS No. 109467-92-6, and has been synthesized for use as an analytical reference standard and impurity standard in drug development studies. 5FAMPO is a synthetic molecule that has not been found in nature, but is structurally similar to natural molecules. 5FAMPO is metabolized by CYP450 enzymes to produce 2-(tert-butylamino)-4'-hydroxyphenylacetic acid (HPA), which can be quantified by HPLC analysis. 5FAMPO is also used as a research and development compound and pharmacopoeia impurity standard.</p>

<p>9-Oxo azithromycin B is a metabolite of azithromycin. It is an analytical standard for the HPLC analysis of azithromycin and its metabolites. 9-Oxo azithromycin B has been shown to bind to the ribosomes of bacteria, and inhibit protein synthesis. This drug also has antibiotic activity against Mycobacterium avium and Mycobacterium tuberculosis. 9-Oxo azithromycin B can be used in niche research or as an API impurity.br&gt;<br>br&gt;<br>br&gt;</p>

<p>N-(((5S)-3-(4-(4-Morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl) acetamide is an impurity of the antibiotic linezolid. It is a contaminant that can be found in urine and blood samples. N-(((5S)-3-(4-(4-Morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl) acetamide has been shown to be amyloidogenic, meaning it can form plaques in the brain and lead to Alzheimer's disease.</p>

<p>3-(4-(4-Morpholinyl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one is an impurity in the drug development process. It is used as a standard for HPLC testing and a synthetic intermediate. It has been shown to have niche use in the pharmaceutical industry. 3-(4-(4-Morpholinyl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one has been found to be metabolized through oxidation and reduction reactions, leading to the formation of metabolites such as 2,6-dihydroxypyridine (DHP). Further metabolism studies are required for this substance.</p>

<p>Cefazolin impurity A is a by-product in the synthesis of Cefazolin, which is a drug product. It has CAS No. 30246-33-4 and is used as an impurity standard for analytical purposes. The Impurity Standard is also known as Metabolite A. Research and Development (R&amp;D) studies are needed to identify the appropriate analytical impurities for this API, which will be reported on Pharmacopoeia's List of Impurities for reference. The high purity and custom synthesis of this API makes it ideal for use in R&amp;D studies, HPLC standards, or niche markets.<br>CAS No.: 30246-33-4<br>Synonyms: Metabolite A<br>Formula: C11H14N2O5S <br>Molecular weight: 289.24 g/mol <br>Appearance: white solid powder</p>

<p>This product is a metabolite of the drug product and impurity standard. It has been synthesized as a custom synthesis to meet the needs of research and development, pharmacopoeia, or natural products. This compound is an API impurity that has been characterized by HPLC. The purity of this product is high, with a minimum purity of 98%.</p>

<p>Roxithromycin impurity E is a metabolite of roxithromycin. It is a yellow powder with a melting point of about 130°C and a molecular weight of 226.14g/mol. Roxithromycin impurity E has been shown to be an inhibitor of CYP3A4 and CYP2D6, as well as an inducer of CYP1A2. This impurity can be used for the research and development of roxithromycin, as well as production of analytical standards for HPLC analysis.</p>

<p>Cefadroxil is a cephalosporin antibiotic that is used to treat bacterial infections. Cefadroxil is metabolized into cefadroxil dimer, an impurity found in the drug product. The impurity standard for cefadroxil dimer was developed by HPLC and has been tested for use as a reference material and can be used in metabolism studies. This impurity standard has been shown to have a purity of 98%.</p>

<p>Clarithromycin EP Impurity K is an impurity standard for Clarithromycin in the form of a crystalline white powder. It is a synthetic compound which has been used as a drug product and as an analytical standard. This compound can be synthesized from erythromycin A, but it is not active against bacteria. Clarithromycin EP Impurity K has been shown to have metabolite properties in animals and humans, including metabolism studies with HPLC standards.</p>

<p>3-(3-Fluoro-4-(4-morpholinyl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one is a synthetic compound with research and development, impurity standard, custom synthesis, drug product, synthetic, high purity and pharmacopoeia applications. It is an impurity standard for the production of 3-[3-fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)oxazolidin-2-one hydrochloride (CAS No. 513068-96-7). This compound has been synthesized in order to study the metabolism of this metabolite. Metabolism studies have indicated that 3-(3-fluoro-4-(4-morpholinyl)phenyl)-5-(hydroxymethyl)oxazolidin-2 one is rapidly metabolized to form 3-[3-[(1S)-1,2,2</p>

<p>2H,5H-Pyrano[4,3-b]pyranyl mupirocin sodium impurity is an impurity standard that has been custom synthesized for research and development purposes. It has a CAS number of 116182-44-6, which is the same as the parent compound. 2H,5H-Pyrano[4,3-b]pyranyl mupirocin sodium impurity is a metabolite of Mupirocin Sodium (CAS No. 99765-92-8). This impurity has been used in pharmacopoeia drug development and for analytical studies such as HPLC.</p>

<p>Tacrolimus Impurity 6 is a product that is custom-synthesized by our company. It is a high purity, analytical standard used in the study of drug metabolism. This impurity can be found in the natural form and as a synthetic compound. It has been shown to act as an inhibitor of protein synthesis, which may be due to its inhibition of methionine synthase activity.</p>

<p>3'-N,N-Didesmethyl-N-(methoxycarbonyl) azithromycin is a research and development impurity standard. It is synthesized by reacting 3-desacetylazithromycin with methoxycarbonyl chloride in the presence of triethylamine. This product has been tested for purity by HPLC. CAS No. 16892-65-2</p>

<p>Please enquire for more information about Amikacin EP impurity G including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Erythromycin impurity M is a natural, API impurity (impurity standard) that is a metabolite of erythromycin. It has been synthesized as a high purity HPLC standard to meet the requirements of pharmacopoeia and drug development. Erythromycin impurity M is an analytical reference material with CAS number 528-73-2.</p>

<p>Micafungin impurity B is a natural metabolite of micafungin. It is a synthetic impurity standard used in HPLC analysis. Micafungin impurity B has been shown to be the primary metabolite of micafungin in humans and is excreted in the urine and feces. Metabolism studies have shown that it may be formed by oxidation of the hydroxyl group at position C-3 or by hydrolysis of the amide bond between carbons C-4 and C-5.</p>

<p>Cephalosporin impurity is an industrial by-product that is generated during the production of cephalosporins. It is a white powder that has no known toxicological effects. Cephalosporin impurity can be used as a supplement in inoculated soil to increase the yield of cephalosporium, which is a fungus that produces cephalosporins.</p>

<p>N-(((5R)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide (LFMAPO) is an antibacterial agent that inhibits bacterial growth by binding to the active site of bacterial DNA gyrase. LFMAPO has a molecular weight of 552.2 Da and a log P value of 2.6. It was synthesized from acetamide, 3-fluoroaniline, and 4-(4-morpholinyl)benzaldehyde in 60% yield using techniques such as millimolar stoichiometry, electrophoresis method, binding constants, and molecular modeling study. The drug also has chiral properties with two stereocenters at carbons C1 and C5 that have been shown to be important for the activity of this compound against Gram positive bacteria.</p>

<p>Ciprofloxacin impurity A is an analog of ciprofloxacin and is a pharmaceutical preparation that belongs to the class of fluoroquinolones. It has been shown to be active against P. aeruginosa and other gram-negative bacteria in wastewater treatment systems. Ciprofloxacin impurity A is activated by ethylene diamine and can be eluted with acidic solvents. It also inhibits tumor cell line growth through adsorption mechanism and is used as a drug for cancer chemoprevention in combination with malic acid.</p>

<p>(R)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one (FPH) is a synthetic drug product that is used as an impurity standard in the synthesis of pharmaceuticals. It is also used in metabolism studies and research and development. FPH has been shown to be a metabolite of the drug product, 3-(3-fluoro-4-(4-morpholinyl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one, which is classified as an API impurity for pharmacopoeia purposes. FPH has a molecular formula of C11H14FO2N2O and a molecular weight of 222.26 g/mol. The CAS number for FPH is 168828-82-8.</p>

<p>Ceftazidime impurity B is a ceftazidime impurity that is found in the drug Ceftazidime. Ceftazidime is an antibiotic that belongs to the group of cephalosporin antibiotics and inhibits bacterial growth by inhibiting cell wall synthesis. Ceftazidime impurity B has been shown to be toxic to gram-positive bacteria, such as Enterococcus faecium and Staphylococcus aureus, but not to gram-negative bacteria, such as Escherichia coli. In addition, it has been shown to have no effect on the IL-2 receptor of T cells or the binding of penicillin-binding protein. It has also been shown to be safe for injection into mice and rats in toxicity studies.</p>

<p>Applications 1-Cyclopropyl-8-ethoxy-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester is used in the preparation of alkoxyquinolone antibacterial agents. Also an impurity in the synthesis of Moxifloxacin (M745000), a fluorinated quinolone antibacterial.<br>References Sanchez, J. et al.: J. Med. Chem., 38, 4478 (1995); Woodcock, J.M., et al.: Antimicrob. Ag. Chemother., 41, 101 (1997), Stass, H., et al.: Antimicrob. Ag. Chemother., 42, 2060 (1998)<br></p>

<p>Applications 4-[4-(4-Nitrophenyl)-1-piperazinyl]phenol is a key intermediate in the synthesis of triazole medicines, such as itraconazole (I937500), which are used in curing deep department fungal infections. Inhibitor of endothelial cell proliferation.<br>References Ke, C. et al.: Adv. Nat. Sci., 2, 26 (2009); Shi, W. et al.: J. Med. Chem., 54, 7363 (2011);<br></p>

<p>Stability Hygroscopic<br>Applications Desacetyl-N,O-descarbonyl Linezolid is an impurity of Linezolid (L466500); an oxazolidinone antimicrobial that inhibits bacterial mRNA translation.<br>References Brickner, S.J., et al.: J. Med. Chem., 39, 673 (1996); Ford, C.W., et al.: Antimicrob. Agents Chemother., 40, 1508 (1996); Rybak, M.J., et al.: Pharmacotherapy, 18, 456 (1998); Stevens, D.L., et al.: Clin. Infect. Dis., 34, 1481 (2002)<br></p>

<p>Applications 8-Epitacrolimus is a new l-pipecolic acid macrolide lactone, an important immunosuppressive drug that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. 8-Epitacrolimus is also an Epimer of Tacrolimus (F370000).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Skytte, D.M., et al.: J. Nat. Prod.,73, 776 (2010); Rokaw, M.D., et al.: Am. J. Physiol., 271, C194 (1996); Knoll, G.A., and Bell, R.C.: Brit. Med. J., 318, 1104 (1999);<br></p>

<p>Stability Hygroscopic, Temperature Sensitive<br>Applications Amoxicillin trimer Trisodium Salt, is an impurity of Amoxicillin (A634235), a β-lactam family antibiotic that is commonly used in conjunction with clavulanic acid (C56370) to the treat bacterial infections.<br>References Gurwith, M., et al.: Antimicrob. Agents Ch., 24, 716 (1983); Kumar, A., et al.: J. Mater. Chem., 20, 10152 (2010);<br></p>

<p>Applications FR 179642 is an impurity of Micafungin (M342350), a lipopeptide compound that acts as an antifungal agent with activity against Aspergillus and Candida species.<br>References Denning, D., et al.: J. Infection, 53, 337 (2006); Queiroz-Telles, F., et al.: Pediatr. Infect. Dis. J., 27, 820 (2008)<br></p>

<p>Chloramphenicol stearate is an antibiotic useful for the therapy of numbers of bacterial infections. This includes an eye ointment to treat conjunctivitis.</p>

<p>Caspofungin impurity A is an impurity found in caspofungin, a drug used to treat fungal infections. Caspofungin impurity A has been shown to inhibit bacterial growth and is thought to be responsible for the bactericidal activity of caspofungin.</p>

<p>Chloramphenicol palmitate is a broad-spectrum antibiotic effective against various bacteria and used for bacterial selection in gene studies.</p>

<p>L-(+)-Ampicillin is an isomer of Ampicillin. Ampicillin is a β-lactam antibiotic used for treating bacterial infections.</p>

<p>Ceftezole: alpha-glucosidase inhibitor, anti-diabetic, broad-spectrum antibiotic for gram-positive/negative bacteria.</p>

<p>Applications Amoxicillin sodium (Amox) (cas# 34642-77-8) is a useful research chemical.<br></p>

<p>Stability Hygroscopic<br>Applications Clindamycin (C580000) impurity in bulk drug.<br>References Zhou, H., et al.: J. Pharma. Biomed. Anal., 41, 1116 (2006),<br></p>

<p>Applications 2,3,4,5-Tetrafluorobenzoic Acid is used in the synthesis of diterpenoid analogs as antitumor compounds. Also used in the synthesis of novel quinoline lactones.<br>References Li, D. et al.: Eur. J. Med. Chem., 64, 215 (2013); Zheng, H. et al.: Lett. Org. Chem., 10, 252 (2013);<br></p>

<p>Impurity Potassium Clavulanate EP Impurity K<br>Applications tert-Octylamine (Potassium Clavulanate EP Impurity K) is used in the synthesis of aminomethyltetracycline dericatives as novel antibacterial agents. Also used in the preparation of carbonyl or sulfonylpyrrolidine containing uracil derivatives which have potent effect in the inhibitoon of deoxyuridine triphosphatase inhibitors.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Clark, R. et al.: J. Med. Chem., 56, 8112 (2013); Miyakoshi, H. et al.: J. Med. Chem., 55, 2960 (2012);<br></p>

<p>Applications The epothilones are a novel class of antineoplastic agents possessing antitubulin activity. Epothilone A, B isolated from Sorangium cellulosum was associated with cell cycle arrest at G2/M transition and apoptosis that was resisted with overexpression of β-tubulin and P-glycoprotein in human bladder carcinoma cell.<br>References Bollag, D.M., et al.: Cancer. Res., 55, 2325 (1995), Hardt, I.H., et al.: J. Nat. Prod., 64, 847 (2001), Gerth, K., et al.: J. Antibiot., 55, 41, 45 (2002)<br></p>

<p>Applications (6R,7S)-Cefoperazone Sodium Salt is the enantiomer of Cefoperazone (C242900) as an impurity.<br>References Fabre, H., et al.: J. Pharm. Sci., 73, 611 (1984), Strasters, J., et al.: Anal. Chem., 63, 2503 (1991), Chen, Z., et al.: World Notes Antibiot., 25, 249 (2004),<br></p>